Delivery Order 36F79723D0188-70B04C25F00000681
Award Date
8/1/25
Potential Completion Date
9/30/25
Potential Value
$112K
Federal Agency
Customs and Border Protection
Awardee
Emergent Devices, Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
Q999 - Medical- Other
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
PLYMOUTH MTNG, PA 19462, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Homeland Security Customs and Border Protection awarded a Firm Fixed Price Delivery Order to Emergent Devices, Inc., a for-profit manufacturer, for the provision of nose spray. The contract, which has a potential value of $152,712.00, was awarded on June 12, 2020 and is set to be completed by June 30, 2020. The contract was issued under Emergent Devices' Federal Supply Schedule contract for Pharmaceuticals and Drugs (FSS-61-IB). No set-aside designation was used for this award....
This federal contract award is for the delivery of NOSE SPRAY to the U.S. Customs and Border Protection (CBP), a civilian agency. The $148,262.40 firm fixed-price delivery order was awarded on August 27, 2018 to Emergent Devices, Inc., a for-profit pharmaceutical manufacturer that specializes in providing medical countermeasures to the U.S. government, with a focus on naloxone products used to reverse opioid overdoses. Emergent Devices holds multiple federal contracts and grant sub-awards to...
The Department of Homeland Security Customs and Border Protection awarded a firm-fixed-price delivery order to Emergent Devices, Inc., a for-profit manufacturer, for the provision of naloxone/NARCAN nasal spray. The $150,465.60 contract has an August 2019 completion date and is not set aside. Emergent Devices holds a Federal Supply Schedule pharmaceutical contract with the Department of Veterans Affairs and has also received federal grant sub-awards to support naloxone distribution efforts. This...
This federal contract award is for Emergent Devices, Inc. to procure 4,320 two-dose cycles (8,640 courses) of NARCAN (naloxone HCI) nasal spray 4mg applicator/cartridges for the U.S. Customs and Border Protection agency. The contract has a ceiling value of $162,820.80 and a completion date of September 30, 2024. This is a firm fixed-price delivery order contract with no set-aside designation. Emergent Devices, a for-profit pharmaceutical manufacturer, is the prime contractor on this award. The...
This is a delivery order awarded by the Federal Emergency Management Agency (FEMA) to Emergent Devices, Inc., a for-profit pharmaceutical manufacturer, for the purchase of NARCAN nasal spray in support of FEMA's Environmental, Safety & Health Division operations. The award is for a Firm Fixed Price contract with a ceiling value of $18,995.76 and a completion date of June 1, 2024. Emergent Devices is a subsidiary of Emergent BioSolutions and is a key supplier of naloxone products to various...
The Department of Homeland Security Customs and Border Protection (DHS CBP) awarded a $293,068.80 delivery order contract to Emergent Devices Inc. under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) master contract. The firm fixed price contract is for the purchase of NARCAN to be delivered to Boston, MA between July 25, 2022 and September 30, 2022. NARCAN is the brand name for naloxone, a medication used to block the effects of opioids, specifically reversing overdoses. No...
This federal contract award was issued by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency within the U.S. Department of Veterans Affairs (VA). The $130,256.64 firm-fixed-price delivery order was awarded to Emergent Devices, Inc., a for-profit pharmaceutical manufacturer, for the supply of NALOXONE HCL 4MG. Emergent Devices, a subsidiary of Emergent BioSolutions, is a key supplier of opioid overdose reversal medications to various federal agencies, including the VA,...
The U.S. Immigration and Customs Enforcement (ICE) awarded a Firm Fixed Price Delivery Order to Emergent Devices, Inc., a manufacturer of pharmaceutical products, for the provision of NARCAN (naloxone nasal spray) with a potential value of $101,310.72. The order was placed under Emergent Devices' Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs (FSS-61-IB). NARCAN is an emergency medication used to rapidly reverse opioid overdoses. Emergent Devices has previously received...
This federal contract award is for the purchase of NARCAN nasal spray by the U.S. Coast Guard, a civilian agency. The $99,908.04 fixed-price purchase order was awarded to Emergent Devices, Inc., a for-profit pharmaceutical manufacturer that specializes in providing medical countermeasures, particularly naloxone products, to various federal agencies. Emergent Devices holds multiple federal contracts and grant sub-awards to supply NARCAN and other naloxone formulations in support of public...
This federal contract award was issued by the Department of Veterans Affairs (VA) Veterans Health Administration to Emergent Devices, Inc., a for-profit manufacturer of pharmaceutical products. The $631,488.00 award is a delivery order under Emergent Devices' existing Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs (FSS-61-IB). The contract is for the provision of pharmaceuticals, with no set-aside designation. Emergent Devices has previously received federal contracts and...